These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7133188)

  • 1. [Prognostic significance of the analysis of estradiol receptor activity in tumor tissue of patients with primary breast carcinoma].
    Raemaekers JM; Beex LV; Koenders AJ; Smals AG; Pieters GF; Benraad TJ; Kloppenborg PW
    Ned Tijdschr Geneeskd; 1982 Aug; 126(33):1493-8. PubMed ID: 7133188
    [No Abstract]   [Full Text] [Related]  

  • 2. [Operable carcinoma of the breast. Prognostic value of estradiol receptors. Preliminary report (author's transl)].
    Cheix F; Biron A; Bailly C; Mayer M; Pommatau E; Saez S
    Nouv Presse Med; 1980 Mar; 9(13):933-5. PubMed ID: 7360626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with prognosis in human breast cancer. III. Estradiol receptors and short term relapse.
    Pascual MR; Macías A; Moreno L; Lage A
    Neoplasma; 1983; 30(5):589-92. PubMed ID: 6656962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estradiol receptor in relation to clinical parameters of mammary tumor patients (author's transl)].
    Görlich M; Heise E
    Arch Geschwulstforsch; 1981; 51(7):631-6. PubMed ID: 7337545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estradiol receptors in the breast neoplasm tissue in menopause].
    Smirnova KD; Murav'eva NI; Vishniakova VV
    Vestn Akad Med Nauk SSSR; 1978; (2):47-50. PubMed ID: 645199
    [No Abstract]   [Full Text] [Related]  

  • 6. Early recurrence in oestrogen receptor negative breast carcinomas. A preliminary report.
    Hartveit F; Maartmann-Moe H; Støa KF; Tangen M; Thorsen T
    Acta Chir Scand; 1980; 146(2):93-5. PubMed ID: 7415751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical factors related to the presence of estrogen receptors in breast cancer: a prognostic stratification analysis.
    Pascual MR; Lazo R; Fernandez L; Lage A
    Neoplasma; 1982; 29(4):453-61. PubMed ID: 7133236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of oestradiol receptor (ER) and histological tumour differentiation with prognosis in human primary breast carcinoma.
    Elston CW; Blamey RW; Johnson J; Bishop HM; Haybittle JL; Griffiths K
    Eur J Cancer (1965); 1980; Suppl 1():59-62. PubMed ID: 7318870
    [No Abstract]   [Full Text] [Related]  

  • 9. Retrospective survey of the clinical significance of cytosolic oestrogen receptor status in 287 patients with primary breast cancer.
    Robinson MF; Savage N; Esser JD; Levin J
    S Afr J Surg; 1985 Sep; 23(3):107-9. PubMed ID: 4049146
    [No Abstract]   [Full Text] [Related]  

  • 10. The prognostic importance of estrogen receptor level for Stage I breast cancer patients.
    Crowe JP; Gordon NH; Hubay CA; Pearson OH; Marshall JS; Mansour EG; Hermann RE; Jones JC; Flynn WJ; McGuire WL
    Curr Surg; 1984; 41(1):24-6. PubMed ID: 6697760
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of estradiol-17 beta receptors in tumorous breast tissue as an index of the hormonal dependence of the tumor].
    Vitova GIa; Olinia AIa; Grabovskaia IK; Priedite IIu
    Vopr Onkol; 1979; 25(5):23-5. PubMed ID: 462848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relation between estrogen receptors and the clinical morphological characteristics of primary breast cancer].
    Vishniakova VV; Ermilova VD; Murav'eva NI; Bassalyk LS
    Arkh Patol; 1981; 43(7):20-3. PubMed ID: 7271502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol receptor levels in human breast carcinomas.
    Bird CE; Houghton B; Westenbrink W; Tenniswood M; Sterns EE; Clark AF
    Can Med Assoc J; 1981 Apr; 124(8):1010-2. PubMed ID: 7260784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early recurrence in breast cancer with efferent vascular invasion: a preliminary report.
    Hartveit F; Støa KF; Tangen M
    Invest Cell Pathol; 1980; 3(2):141-5. PubMed ID: 7380665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Steroid hormone receptors and their relevance for the therapy of mammary cancers (author's transl)].
    Heise E
    Arch Geschwulstforsch; 1981; 51(8):727-36. PubMed ID: 7041847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormonal receptors: methods and prognostic significance].
    Barengo R; Giai M; Corradin MP; Cortese P; Genta F
    Minerva Ginecol; 1985 Jun; 37(6):307-15. PubMed ID: 4034077
    [No Abstract]   [Full Text] [Related]  

  • 17. 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.
    Jansson AK; Gunnarsson C; Cohen M; Sivik T; Stål O
    Cancer Res; 2006 Dec; 66(23):11471-7. PubMed ID: 17145895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value of receptor state determined by radiometric method in breast carcinoma].
    Campobasso O; Chasseur D; Concina S; Conti G; Cozzani C; Racca S
    Pathologica; 1985; 77(1049):315-21. PubMed ID: 3831882
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.
    Turner BC; Gumbs AA; Carbone CJ; Carter D; Glazer PM; Haffty BG
    Cancer; 2000 Mar; 88(5):1091-8. PubMed ID: 10699900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptors in early breast cancer.
    Cooke T; George D; Schields R; Maynard PV; Griffiths K
    Eur J Cancer (1965); 1980; Suppl 1():53-7. PubMed ID: 7318869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.